Polo-Like Kinase 4 Inhibition: A Strategy for Cancer Therapy?

Cancer Cell - United States
doi 10.1016/j.ccr.2014.07.017
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Modulating Polo-Like Kinase 1 as a Means for Cancer Chemoprevention

Pharmaceutical Research
Organic ChemistryBiotechnologyMolecular MedicinePharmacologyPharmaceutical Science
2010English

A Perspective on Polo-Like Kinase-1 Inhibition for the Treatment of Rhabdomyosarcomas

Frontiers in Oncology
Cancer ResearchOncology
2019English

Polo-Like-Kinase 1: A Key Cellular Target for Anti-HBV Therapy?

Hepatology
MedicineHepatology
2017English

A Novel Treatment Strategy Targeting Polo-Like Kinase 1 in Hematological Malignancies

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2009English

Enabling and Disabling Polo-Like Kinase 1 Inhibition Through Chemical Genetics

ACS Chemical Biology
BiochemistryMedicineMolecular Medicine
2012English

Cell Type Dependent Effects of Polo-Like Kinase 1 Inhibition Compared With Targeted Polo Box Interference in Cancer Cell Lines

Molecular Cancer Therapeutics
Cancer ResearchOncology
2007English

Inhibition of Polo-Like Kinase 1 (Plk1) Enhances the Antineoplastic Activity of Metformin in Prostate Cancer

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2014English

Downregulation of Human Polo-Like Kinase Activity by Antisense Oligonucleotides Induces Growth Inhibition in Cancer Cells

Oncogene
Cancer ResearchGeneticsMolecular Biology
2002English

Polo-Like Kinase 4 Kinase Activity Limits Centrosome Overduplication by Autoregulating Its Own Stability

Journal of Cell Biology
MedicineCell Biology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy